Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result

Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result

<strong>Background:</strong> Blood biomarkers may aid in recruitment to clinical trials of Alzheimer’s disease (AD) modifying therapeutics by triaging potential trials participants for amyloid positron emission tomography (PET) or cerebrospinal fluid (CSF) Aβ and tau tests. <strong&g...

书目详细资料
Main Authors:	Westwood, S, Baird, AL, Hye, A, Ashton, NJ, Nevado-Holgado, AJ, Anand, SN, Liu, B, Newby, D, Bazenet, C, Kiddle, SJ, Ward, M, Newton, B, Desai, K, Hehir, C, Zanette, M, Galimberti, D, Parnetti, L, Lleó, A, Baker, S, Narayan, VA, Van Der Flier, WM, Scheltens, P, Teunissen, CE, Visser, PJ, Lovestone, S
格式:	Journal article
出版:	Frontiers Media 2018

相似书籍

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
由: Sarah Westwood, et al.
出版: (2018-12-01)

The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
由: Westwood, S, et al.
出版: (2017)

New CSF biomarkers on the block
由: Charlotte E Teunissen, et al.
出版: (2016-09-01)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
由: Rosha Babapour Mofrad, et al.
出版: (2019-12-01)

Determining the molecular pathways underlying the protective effect of non-steroidal anti-inflammatory drugs for Alzheimer's disease: A bioinformatics approach
由: Nevado-Holgado, A, et al.
出版: (2016)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
由: Eleonora M. Vromen, et al.
出版: (2022-01-01)

Blood-based proteomic biomarkers of Alzheimer’s disease pathology
由: Baird, A, et al.
出版: (2015)

Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
由: Alejo J Nevado-Holgado, et al.
出版: (2017-01-01)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
由: Betty Marije Tijms, et al.
出版: (2021-08-01)

Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
由: Yong-Jin Park, et al.
出版: (2025-01-01)

Amyloid-Targeting PET Tracer [18F]Flutemetamol Accumulates in Atherosclerotic Plaques
由: Sanna Hellberg, et al.
出版: (2019-03-01)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
由: Teunissen, C, et al.
出版: (2018)

Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
由: Lyduine E. Collij, et al.
出版: (2023-11-01)

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
由: Si Eun Kim, et al.
出版: (2020-01-01)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
由: Eline A. J. Willemse, et al.
出版: (2021-01-01)

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice.
由: Stephanie J B Vos, et al.
出版: (2014-01-01)

Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study
由: Yanaika S. Hok‐A‐Hin, et al.
出版: (2023-07-01)

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease
由: Winchester, L, et al.
出版: (2018)

Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
由: Mark R. Battle, et al.
出版: (2018-12-01)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
由: Charlotte E. Teunissen, et al.
出版: (2018-03-01)

Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.
由: Vandenberghe, R, et al.
出版: (2013)

Early-phase 18F-FP-CIT and 18F-flutemetamol PET were significantly correlated
由: Young-Sil An, et al.
出版: (2021-06-01)

Temporal and anatomical distribution of 18F-flutemetamol uptake in canine brain using positron emission tomography
由: Taesik Yun, et al.
出版: (2020-01-01)

PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
由: Juhan Reimand, et al.
出版: (2019-12-01)

Blood-based biomarker candidates of cerebral amyloid using PiB PET in non-demented elderly
由: Westwood, S, et al.
出版: (2016)

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
由: Vandenberghe, R, et al.
出版: (2010)

Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
由: Hugh G. Pemberton, et al.
出版: (2023-05-01)

Automatic lesion detection and segmentation in 18F-flutemetamol positron emission tomography images using deep learning
由: Chan Ju Ryu
出版: (2022-12-01)

Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
由: Fiona Heeman, et al.
出版: (2019-03-01)

Cross-sectional and longitudinal analyses of outdoor air pollution exposure and cognitive function in UK Biobank
由: Cullen, B, et al.
出版: (2018)

Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank
由: Nevado-Holgado, A, et al.
出版: (2016)

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and CSF
由: Winchester, L, et al.
出版: (2022)

18F-flutemetamol PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer's disease：a preliminary study
由: LEI Zhe, et al.
出版: (2022-07-01)

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques
由: Milos D. Ikonomovic, et al.
出版: (2018-06-01)

Quantitative Evaluation of 18F-Flutemetamol PET in Patients With Cognitive Impairment and Suspected Alzheimer's Disease: A Multicenter Study
由: Hiroshi Matsuda, et al.
出版: (2021-01-01)

Blood based proteomic biomarkers of Alzheimer’s disease pathology
由: Alison Louise Baird, et al.
出版: (2015-11-01)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
由: Carla M. Startin, et al.
出版: (2019-03-01)

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer’s disease
由: Laura M. Winchester, et al.
出版: (2018-06-01)

Synaptic protein CSF levels relate to memory scores in individuals without dementia
由: Wesenhagen, KEJ, et al.
出版: (2025)

Synaptic protein CSF levels relate to memory scores in individuals without dementia
由: Kirsten E. J. Wesenhagen, et al.
出版: (2025-03-01)